> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Information Collection Revision for Biosimilar User Fees
- URL: https://www.fdaweb.com/information-collection-revision-for-biosimilar-user-fees/
- Published: 2018-06-25T12:00:00.000Z
- Updated: 2026-09-15T00:15:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141759

*Federal Register* notice: FDA has submitted for OMB approval an information collection revision entitled “Guidance for Industry: Assessing User Fees Under the Biosimilar User Fee Amendments of 2017” (OMB Control Number 0910-0718). To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-13688.pdf?ref=fdaweb.com).